KAPLAN MATTHEW L. received a stock award from NUVECTIS PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/20/2023ACC: 0001104659-23-072606
+18K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
18K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+18K
Price / share
—
Trade value
—
% of position
50.3%
6/16/2023
35.76K→53.76K
Total
Net shares
+18K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/16/2023 | A · Award | +18K | — | — | 50.3% | 35.76K | 53.76K |
| Total | +18K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported